Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael J Mant

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
American Journal of Hematology|April 1, 2004
Prompt response to rituximab of severe hemolytic anemia with both cold and warm autoantibodiesDuncan Webster, Bruce Ritchie, Michael J Mant
Acta Orthopaedica|December 17, 2008
Post-thrombotic syndrome after total hip arthroplasty is uncommonMichael J Mant, Dean T Eurich, Donald B Russell, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 18, 2006
Prevalence of occult gastrointestinal bleeding in celiac diseaseMichael J Mant, Vincent G Bain, Conor G Maguire, et al.
Seminars in Oncology|April 30, 2003
Abnormal expression of hyaluronan synthases in patients with Waldenstrom's macroglobulimeniaSophia Adamia, Mary Crainie, Jitra Kriangkum, et al.
Blood|February 26, 2005
Intronic splicing of hyaluronan synthase 1 (HAS1): a biologically relevant indicator of poor outcome in multiple myelomaSophia Adamia, Tony Reiman, Mary Crainie, et al.
Seminars in Oncology|April 30, 2003
The malignant clone in Waldenstrom's macroglobulinemiaJitra Kriangkum, Brian J Taylor, Michael J Mant, et al.
Blood|February 7, 2004
Clonotypic IgM V/D/J sequence analysis in Waldenstrom macroglobulinemia suggests an unusual B-cell origin and an expansion of polyclonal B cells in peripheral bloodJitra Kriangkum, Brian J Taylor, Steven P Treon, et al.
Clinical Medicine. Oncology|September 6, 2011
Multiple Myeloma Includes Phenotypically Defined Subsets of Clonotypic CD20+ B Cells that Persist During Treatment with RituximabLinda M Pilarski, Eva Baigorri, Michael J Mant, et al.
Blood|December 1, 2005
Impaired class switch recombination (CSR) in Waldenstrom macroglobulinemia (WM) despite apparently normal CSR machineryJitra Kriangkum, Brian J Taylor, Erin Strachan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2002
Intraclonal homogeneity of clonotypic immunoglobulin M and diversity of nonclinical post-switch isotypes in multiple myeloma: insights into the evolution of the myeloma cloneBrian J Taylor, Julie A Pittman, Karen Seeberger, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
American Journal of Hematology|April 1, 2004
Prompt response to rituximab of severe hemolytic anemia with both cold and warm autoantibodiesDuncan Webster, Bruce Ritchie, Michael J Mant
Acta Orthopaedica|December 17, 2008
Post-thrombotic syndrome after total hip arthroplasty is uncommonMichael J Mant, Dean T Eurich, Donald B Russell, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 18, 2006
Prevalence of occult gastrointestinal bleeding in celiac diseaseMichael J Mant, Vincent G Bain, Conor G Maguire, et al.
Seminars in Oncology|April 30, 2003
Abnormal expression of hyaluronan synthases in patients with Waldenstrom's macroglobulimeniaSophia Adamia, Mary Crainie, Jitra Kriangkum, et al.
Blood|February 26, 2005
Intronic splicing of hyaluronan synthase 1 (HAS1): a biologically relevant indicator of poor outcome in multiple myelomaSophia Adamia, Tony Reiman, Mary Crainie, et al.
Seminars in Oncology|April 30, 2003
The malignant clone in Waldenstrom's macroglobulinemiaJitra Kriangkum, Brian J Taylor, Michael J Mant, et al.
Blood|February 7, 2004
Clonotypic IgM V/D/J sequence analysis in Waldenstrom macroglobulinemia suggests an unusual B-cell origin and an expansion of polyclonal B cells in peripheral bloodJitra Kriangkum, Brian J Taylor, Steven P Treon, et al.
Clinical Medicine. Oncology|September 6, 2011
Multiple Myeloma Includes Phenotypically Defined Subsets of Clonotypic CD20+ B Cells that Persist During Treatment with RituximabLinda M Pilarski, Eva Baigorri, Michael J Mant, et al.
Blood|December 1, 2005
Impaired class switch recombination (CSR) in Waldenstrom macroglobulinemia (WM) despite apparently normal CSR machineryJitra Kriangkum, Brian J Taylor, Erin Strachan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2002
Intraclonal homogeneity of clonotypic immunoglobulin M and diversity of nonclinical post-switch isotypes in multiple myeloma: insights into the evolution of the myeloma cloneBrian J Taylor, Julie A Pittman, Karen Seeberger, et al.
Pageof 2